Low doses of penta-brominated diphenyl ether flame retardants alter gene expression

April 13, 2011

Polybrominated diphenyl ethers (PBDEs) are chemicals that have been widely used as flame retardants and are now classified as persistent organic pollutants. Health concerns in humans have arisen based primarily on studies with laboratory animals exposed to high levels of PBDEs.

Three commercial mixtures of PBDEs have been manufactured in or imported into the United States which include penta-, octa-, and deca-brominated diphenyl ethers (BDEs). Of particular concern has been the penta-BDEs used primarily in foams in computers, televisions, mattresses, pillows, carpets, and furniture. The components of penta-BDEs mixtures are present in water, soil, animal products and air, and people are exposed primarily through ingestion of food or inhalation. Penta-BDEs have been measured in human blood, fat, , and umbilical cord blood. Since 2004, the penta- and octa-BDEs are no longer being manufactured in the USA and deca-BDE manufacture in the USA will be phased out by the end of 2013. Even so, due to their chemical nature, PBDEs will persist in the environment long after their use in manufacturing has ended. It is unclear what impact PBDEs have on human health as people are typically not exposed to the high concentrations of PBDE compounds that have detrimental neurological and endocrine effects in laboratory animals. There is a need to determine the impact of low doses of PBDEs in laboratory animals which approach the levels that humans are exposed to in daily life, and in addition to determine the effects of these compounds in offspring exposed during critical developmental periods.

In the work published in the April issue of , Blake, LaVoie, and co-investigators set out to determine the effects of a relatively low dose of the commercial penta-BDE mixture, DE-71, on reproductive and endocrine function in a laboratory rat model. Female rats were orally administered 60 micrograms/kilogram body weight/day during pregnancy and lactation to expose them and their developing offspring to DE-71. The offspring were followed to adulthood and mated to evaluate their reproductive outcomes, thyroid hormone concentrations, body and organ weights, and gene expression in selected organs. The work was carried out jointly by the laboratories of Charles A. Blake and Holly A. LaVoie at the University of South Carolina School of Medicine in Columbia, South Carolina.

Dr. LaVoie, who led the research team, stated "we were happy to see that low doses of DE-71 did not overtly affect reproductive outcome of pregnancy in terms of resorbed embryos and number of viable offspring of either the mothers receiving DE-71 or their first generation offspring. However, gene profiling of reproductive organs of offspring identified a single gene spp1 that encodes osteopontin, which exhibited 3-fold or higher expression in both the immature testes of male offspring and adult ovaries of female offspring that were exposed to low dose DE-71 in utero and via their mother's milk. This shows that molecular changes are occurring in reproductive organs and that some of these molecular changes appear even after the penta-BDE delivery was ceased."

Additional cell culture studies further confirmed that the osteopontin gene promoter is a novel target of PBDEs. Osteopontin is a multi-functional extracellular matrix protein. The long-term implications of elevated osteopontin gene expression in gonads is unclear at this time, however, osteopontin protein is known to be elevated in ovarian and other cancers. PBDEs are formed by adding 1-10 bromine groups to a double ring structure to form different congeners. Different PBDE congeners can mimic or inhibit thyroid hormone, estrogen, and androgen function. The mechanism of how PBDEs regulate the osteopontin gene will require further study. Also in need of further study are the long-term implications of altered osteopontin in ovaries and testes.

In contrast to prior studies with much higher concentrations of penta-BDEs that demonstrated reduced serum thyroid hormone concentrations, the study showed that first generation females during their own pregnancies had elevated serum thyroid hormones. Furthermore, the DE-71 exposed female offspring sacrificed two months after their own pregnancies, had enlarged thyroids without altered serum thyroid hormones.

Dr. Blake, who led the endocrine studies remarked, "Our thyroid findings, taken together with previous work with high doses of penta-BDEs, indicate that these compounds may have biphasic effects depending on exposure levels where low dose exposures may increase thyroid hormone concentrations and higher PBDE doses may decrease them. In addition, the physiological status of the animal (i.e., pregnant versus non-pregnant) may determine if the thyroid hormone levels are affected. These studies could potentially be critical to understanding the effects of PBDE accumulation in the tissues of pregnant women. They also emphasize the potential importance of reducing exposure to PBDEs in homes and the environment and regulating the import of manufactured items that contain PBDEs."

The first generation offspring in the study received DE-71 via maternal exposure to a low dose, showing that in utero and lactational exposure of offspring can have effects lasting into adulthood. Moreover, most differences were observed in female rat offspring, suggesting sex differences in the physiological responses to PBDEs. This study sets the stage for future investigations of long-term effects of low level PBDE ingestion.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "This important environmental health study by Holly Lavoie, Charles Blake and colleagues has looked at the effect of low doses of polybrominated diphenyl ethers (PBDEs) on laboratory animals. Their findings indicate these organic pollutants, found in flame retardents, caused pregnant and lactating rats to have increased levels of in female and increased gonadal osteopontin gene expression. It is clear that this sets the stage for future studies aimed at understanding the long term consequences of PBDE exposure."

Related Stories

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.